Methods and compositions for cancer therapy and for...

Details Methods and compositions for cancer therapy and for... Methods and compositions for cancer therapy and for...

C - Chemistry, Metallurgy

12

P

C12P 21/08 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) C07K 16/30 (2006.01) C07K 16/32 (2006.01) C12Q 1/02 (2006.01) G01N 33/50 (2006.01) G01N 33/566 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2096417

A method for determining the efficacy of a therapeutic agent, in vitro, for a cancer expressing or overexpressing an oncogene product is described. The method is particularly useful for determining the efficacy of therapeutic agents that have a binding affinity for cancer that express HER-2/neu. N24, N28 and N29 monoclonal antibodies are described which have been identified by this method. One or more of these antibodies can be used as a therapeutic agent in the treatment of breast, stomach, ovarian or salivary cancers.

Procédé de détermination de l'efficacité d'un agent thérapeutique, in vitro, utilisé dans le traitement d'un cancer caractérisé par l'expression ou la surexpression d'un produit oncogène. Le procédé est notamment utile pour déterminer l'efficacité d'agents thérapeutiques présentant une affinité de liaison pour le cancer, exprimant HER-2/neu. L'invention concerne également les anticorps monoclonaux N24, N28 et N29 identifiés par ce procédé. On peut utiliser un ou plusieurs de ces anticorps comme agent thérapeutique dans le traitement des cancers du sein, de l'estomac, des ovaires ou des glandes salivaires.

Affiliated with

Also associated with

Rating

Methods and compositions for cancer therapy and for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for cancer therapy and for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for cancer therapy and for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1677601